Abstract
Objective: This research targeted to assess the clinical characteristics of chronic diarrhea in children, and explore the prognostic value of nutritional status and immune indicators.
Methods: A total of 190 patients with chronic diarrhea from January 2017 to June 2020 were enrolled to analyze their epidemiology. The patients were divided into a better prognosis group (cured, improved) and a poor prognosis group (uncured), followed by determining the diagnostic efficacy of nutritional status and immune indicators in the prognosis of children with chronic diarrhea.
Results: Most of the patients were 0-3 years old (74.2%), of which 54.3% were less than 1 year old, and the highest proportion (48.95%) had diarrhea with a course of 1 to 2 months. The levels of albumin, immunoglobulin G (IgG), IgA and IgM, as well as albumin, globulin and the ratio of albumin to globulin in the better prognosis group were higher than those in the poor prognosis group. The AUC (area under the curve) of the combined detection in evaluating the prognosis of children with chronic diarrhea was greater than that of the albumin and globulin alone (P < 0.05). IgG ≥ 10.05g/L and IgA ≥ 7.72g/L were protective factors affecting the prognosis of children with chronic diarrhea.
Conclusion: Children with chronic diarrhea are mainly infants and young children with various clinical symptoms, and are prone to comorbidities such as malnutrition, anemia, hypoalbuminemia, and impaired immune function. The combined detection of nutritional status and immune indicators in children is of value in evaluating the prognosis of children.
Keywords
Array
Array
Array
Array
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.